Boothbay Fund Management, LLC Bridge Bio Pharma, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $2.99 Million - $4.42 Million	109,300 New	109,300 $3.38 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $3.17 Million - $6.58 Million	-187,900 Reduced 75.07%	62,400 $1.65 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $61,133 - $82,846	-4,600 Reduced 1.8%	250,300 $4.31 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $1.83 Million - $4.73 Million	254,900 New	254,900 $4.23 Million
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $132,855 - $309,570	25,500 New	25,500 $232,000

Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $206,988 - $483,912	-28,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $320,916 - $1.51 Million	28,200 New	28,200 $470,000

284

170M

7.41M

2.61M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.76B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.